A detailed history of Geneos Wealth Management Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 53,132 shares of PFE stock, worth $1.46 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
53,132
Previous 165,277 67.85%
Holding current value
$1.46 Million
Previous $4.59 Million 67.6%
% of portfolio
0.07%
Previous 0.21%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$25.26 - $29.6 $2.83 Million - $3.32 Million
-112,145 Reduced 67.85%
53,132 $1.49 Million
Q1 2024

May 03, 2024

BUY
$25.89 - $29.73 $57,579 - $66,119
2,224 Added 1.36%
165,277 $4.59 Million
Q4 2023

Jan 26, 2024

SELL
$26.13 - $33.94 $1.04 Million - $1.35 Million
-39,790 Reduced 19.62%
163,053 $4.69 Million
Q3 2023

Oct 11, 2023

BUY
$32.09 - $37.51 $195,749 - $228,811
6,100 Added 3.1%
202,843 $6.73 Million
Q2 2023

Aug 08, 2023

BUY
$36.12 - $41.79 $5.32 Million - $6.16 Million
147,356 Added 298.37%
196,743 $7.22 Million
Q1 2023

Apr 25, 2023

SELL
$39.39 - $51.28 $545,039 - $709,561
-13,837 Reduced 21.89%
49,387 $2.01 Million
Q4 2022

Jan 30, 2023

BUY
$41.75 - $54.5 $80,744 - $105,403
1,934 Added 3.16%
63,224 $3.24 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $1.89 Million - $2.31 Million
-43,287 Reduced 41.39%
61,290 $2.68 Million
Q2 2022

Jul 22, 2022

SELL
$46.53 - $55.17 $20,426 - $24,219
-439 Reduced 0.42%
104,577 $5.48 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $545,202 - $675,574
-11,917 Reduced 10.19%
105,016 $5.44 Million
Q4 2021

Feb 09, 2022

BUY
$41.32 - $61.25 $155,239 - $230,116
3,757 Added 3.32%
116,933 $6.9 Million
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $12,913 - $16,588
329 Added 0.29%
113,176 $4.86 Million
Q2 2021

Jul 08, 2021

SELL
$35.91 - $40.68 $589,354 - $667,640
-16,412 Reduced 12.7%
112,847 $4.48 Million
Q1 2021

Jun 17, 2021

BUY
$33.49 - $37.77 $314,102 - $354,244
9,379 Added 7.82%
129,259 $5 Million
Q4 2020

May 19, 2021

BUY
$33.47 - $42.56 $577,859 - $734,798
17,265 Added 16.83%
119,880 $3.8 Million
Q3 2020

Sep 07, 2021

SELL
$31.75 - $37.25 $730,027 - $856,489
-22,993 Reduced 18.31%
102,615 $3.7 Million
Q2 2020

Sep 07, 2021

BUY
$30.12 - $36.54 $1.19 Million - $1.44 Million
39,346 Added 45.61%
125,608 $4.02 Million
Q1 2020

Sep 07, 2021

BUY
$27.03 - $38.62 $7,892 - $11,277
292 Added 0.34%
86,262 $2.67 Million
Q4 2019

Sep 07, 2021

SELL
$32.92 - $37.36 $119,697 - $135,840
-3,636 Reduced 4.06%
85,970 $3.38 Million
Q3 2019

Sep 07, 2021

SELL
$32.49 - $42.13 $159,103 - $206,310
-4,897 Reduced 5.18%
89,606 $3.25 Million
Q2 2019

Sep 07, 2021

BUY
$36.98 - $41.52 $50,255 - $56,425
1,359 Added 1.46%
94,503 $4.09 Million
Q1 2019

Sep 07, 2021

BUY
$37.5 - $41.2 $234,975 - $258,159
6,266 Added 7.21%
93,144 $3.96 Million
Q4 2018

Sep 07, 2021

BUY
$38.47 - $43.86 $99,444 - $113,378
2,585 Added 3.07%
86,878 $3.73 Million
Q3 2018

Sep 07, 2021

BUY
$34.47 - $41.81 $129,296 - $156,829
3,751 Added 4.66%
84,293 $3.71 Million
Q2 2018

Sep 07, 2021

SELL
$32.98 - $35.16 $251,175 - $267,778
-7,616 Reduced 8.64%
80,542 $2.92 Million
Q1 2018

Sep 07, 2021

SELL
$31.91 - $37.02 $78,658 - $91,254
-2,465 Reduced 2.72%
88,158 $3.13 Million
Q4 2017

Sep 07, 2021

SELL
$33.26 - $35.29 $122,330 - $129,796
-3,678 Reduced 3.9%
90,623 $3.28 Million
Q3 2017

Sep 07, 2021

BUY
$31.0 - $34.15 $105,462 - $116,178
3,402 Added 3.74%
94,301 $3.37 Million
Q2 2017

Sep 07, 2021

SELL
N/A
-1,159 Reduced 1.26%
90,899 $3.05 Million
Q1 2017

Sep 07, 2021

SELL
N/A
-6,078 Reduced 6.19%
92,058 $3.15 Million
Q4 2016

Sep 07, 2021

BUY
N/A
2,561 Added 2.68%
98,136 $3.19 Million
Q3 2016

Sep 07, 2021

SELL
N/A
-1,530 Reduced 1.58%
95,575 $3.24 Million
Q2 2016

Sep 07, 2021

SELL
N/A
-5,488 Reduced 5.35%
97,105 $3.45 Million
Q1 2016

Sep 07, 2021

BUY
N/A
102,593
102,593 $3.07 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.